CiRA (Center for iPS cell Research and Application

Perspectives on high-profile stem cell retraction in the making from Kyoto University

IPS-cell-paper-retraction-requested

A researcher working at Kyoto University has reportedly engaged in misconduct leading to an institutional request for retraction of a paper from the journal Stem Cell Reports. The paper in question appears to have rather large-scale problems: “Kohei Yamamizu, a specially appointed assistant professor at the university’s Center for iPS Cell Research and Application, falsified all …

Perspectives on high-profile stem cell retraction in the making from Kyoto University Read More »

New Yamanaka interview gives key insights into future of IPS cells

Nobel Laureate Shinya Yamanaka, the first to produce induced pluripotent stem cells

Where is the field of IPS cells going and how will this impact the overall field of stem cell-based regenerative medicine? Nobel Laureate Shinya Yamanaka, the discoverer of IPS cells, gave a really interesting recent interview to Nikkei that provides some fascinating insights into the future of this exciting technology that is now more than a decade …

New Yamanaka interview gives key insights into future of IPS cells Read More »

Japan IPS cell trial for vision to start in new incarnation

Masayo-Takahashi

It’s been a long road, but the first ever IPS cell clinical study in humans is starting up again in a new incarnation. You might say it has been regenerated in a novel form. Masayo Takahashi (高橋 政代) first started the pioneering IPS cell study a few years back in 2014, but it ended up …

Japan IPS cell trial for vision to start in new incarnation Read More »

Good stem cell news as Takahashi IPS Cell Trial to Resume

Masayo-Takahashi

Some good news today as the pioneering induced pluripotent stem (IPS) cell trial led by Dr. Masayo Takahashi will resume. This clinical study with a focus on macular degeneration has been on hold for quite some time due to regulatory changes in Japan. There had also been concerns over mutations in the 2nd patient’s IPS …

Good stem cell news as Takahashi IPS Cell Trial to Resume Read More »

Landmark IPSC clinical study on hold due to genomic issue

IPSC-RPE-sheet

The pioneering induced pluripotent stem cell (IPSC) clinical study in Japan led by top stem cell clinical researcher Dr. Masayo Takahashi has been stopped reports the WSJ in Japan. This development is confirmed by other sources and in a PDF report by RIKEN (in Japanese here). One patient was transplanted in September 2014 with their own IPSC-derived …

Landmark IPSC clinical study on hold due to genomic issue Read More »